Dermal

AHK-Cu

Ala-His-Lys copper complex

AHK-Cu is the copper complex of alanyl-histidyl-lysine. Its first residue is alanine, unlike the glycine in GHK-Cu; the two names therefore describe different complexes.

Reviewed September 2026

Residues
3. verified: 3 residues per peptide ligand; this is not an assertion about ligand-to-copper stoichiometry.
Average mass
Not established. unverified: No unique average molecular mass assigned without a specified AHK–Cu coordination/protonation/salt form. The retrieved PubChem name match includes hydrochloride and is not adopted as the reference by assumption.
pI
Not established. unverified: Metal binding changes protonation and charge. A free GHK/AHK peptide pI does not describe the copper complex; no validated complex-specific model or measured value was established.

Reference details

Reference details
Residues3
Average massNot established
pINot established
Identity
AliasesAla-His-Lys copper complex
Research areaDermal

Property basis and sources

These describe the reference compound or formulation, not identification or testing of the supplied lot.

AHK–Cu designates an alanyl–histidyl–lysine/copper complex. Copper stoichiometry, protonation, counterions and hydration require specification; a hydrochloride database synonym is not proof of the sold form.

  • Residues: 3 (verified). 3 residues per peptide ligand; this is not an assertion about ligand-to-copper stoichiometry. Residues source 1
  • Average mass: Not established (unverified). No unique average molecular mass assigned without a specified AHK–Cu coordination/protonation/salt form. The retrieved PubChem name match includes hydrochloride and is not adopted as the reference by assumption. Average mass source 1 Average mass source 2
  • pI: Not established (unverified). Metal binding changes protonation and charge. A free GHK/AHK peptide pI does not describe the copper complex; no validated complex-specific model or measured value was established. pI source 1

Reference scope and linked records

Reference type: Peptide-metal complex.

This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.

Catalogue context: AHK-CU. The product retains its own name and specification; this link does not certify equivalence to published study material.

Related references

Sources and their scope

  1. Effect of tripeptide-copper complex on human hair growth in vitro. Source for the chemistry or study context discussed above; not an Aminos lot certificate.

Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.

About AHK-Cu

Identity and context

The primary hair-follicle study explicitly identifies L-alanyl-L-histidyl-L-lysine-Cu2+. This is enough to distinguish the ligand from GHK, but a supplier specification still needs to define the complex and chemical form of the delivered material.

Reference classification

Peptide-metal complex. The linked catalogue product is AHK-CU. This reference does not independently authenticate the material supplied.

Storage and handling

Analytical specification

Check that the ligand is AHK rather than GHK and that the copper specification is included. A total powder amount does not state copper content, ligand content or the ratio between them.

Storage and experimental handling

Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.

Research evidence

Research evidence for this compound
AreaSummaryEvidence
What the source examinesPyo and colleagues studied isolated human hair follicles ex vivo and cultured dermal papilla cells. They reported follicle elongation and cell proliferation under the tested conditions. The reduction in apoptotic cells was not statistically significant, a qualification that should remain attached to that part of the result.Source context
What cannot be inferredHuman-derived cells or follicles are not a clinical hair-regrowth trial. The study cannot establish a treatment outcome in people or validate the identity of an unrelated catalogue lot.Evidence limits

References

Sources used for the data on this page, checked September 2026.

  1. Effect of tripeptide-copper complex on human hair growth in vitroPrimary source for the reference discussion; not lot-specific product evidence.

Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.